Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
48.37799
male
0
40
MOSF w/Malig
ARF/MOSF
1
12
null
0
149,618
74,711.5
66,629.875
26.25
white
23
49
0.697998
0.60791
4
0
0
yes
0.5
0.2
no dnr
40
45
13.5
100
20
38.29688
null
2.399902
0.199982
1
134
null
77
17
800
0
0
null
0
74
1
74.73199
male
0
19
COPD
COPD/CHF/Cirrhosis
5
7
null
0
24,493
13,656.2188
12,216.4531
13.666664
white
25.199219
54
0.67395
0.501953
1
1
0
yes
0.5
0.45
no dnr
19
119
14
118
11
36.79688
238.09375
1.899902
0.599976
1.199951
113
7.349609
1,092
35
2,370
null
3
null
3
501
1
77.82599
female
0
18
Coma
Coma
0
null
under $11k
9
31,427
17,934.3906
14,550.3125
15.666664
white
20.5
26
0.629883
0.567993
1
0
0
no
0.25
0.1
dnr after sadm
1
121
26.097656
156
40
40.19531
null
3.299805
0.399963
0.799927
132
null
130
10
4,750
null
6
adl>=4 (>=5 if sur)
6
600
0
78.70795
female
0
15
COPD
COPD/CHF/Cirrhosis
2
18
$11-$25k
0
17,883
9,741.2891
9,211.67969
11.666664
white
15.699219
26
0.8479
0.75
1
0
0
no
0.9
0.8
dnr after sadm
7
59
11.798828
62
28
38.5
302
3.599609
null
2
136
7.40918
95
60
2,713
2
null
adl>=4 (>=5 if sur)
1.838867
189
1
82.80096
male
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
4
11
$11-$25k
9
8,501
4,951.0508
4,707.87891
10.5
white
27.699219
37
0.553955
0.440979
1
0
1
yes
0.5
0.2
dnr before sadm
0
59
6.699219
66
28
37.29688
null
2.199707
0.599976
1.799805
134
null
196
88
2,350
null
5
adl>=4 (>=5 if sur)
5
165
1
83.23297
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
null
9
24,143
15,879.9141
14,567.7266
14.666664
white
26.199219
29
0.659912
0.56189
1
0
1
no
0.8
0.8
dnr after sadm
1
113
14.398438
152
36
36.39844
96.65625
3.199707
1.099854
0.899902
142
7.5
108
19
5,065
null
6
adl>=4 (>=5 if sur)
6
400
1
71.81696
male
0
9
COPD
COPD/CHF/Cirrhosis
4
14
$11-$25k
0
21,997
12,084.0312
12,242.7891
17
white
25.097656
25
0.756958
0.61499
1
1
0
no
0.7
0.65
no dnr
9
47
14.099609
58
10
37.79688
87.5
2.799805
0.799927
1
139
7.389648
228
21
848
null
0
no(M2 and SIP pres)
0
598
0
74.13794
female
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
0
27,806
19,504.6719
15,459.8125
13.333328
white
21.296875
37
0.813965
0.751953
1
0
0
no
0.8
0.8
dnr after sadm
1
107
15.298828
112
27
36.69531
242.84375
null
null
1.199951
140
7.439453
150
20
1,670
null
6
adl>=4 (>=5 if sur)
6
593
0
93.21295
female
0
10
CHF
COPD/CHF/Cirrhosis
2
9
null
9
10,108
5,805.0742
5,892.50781
11.5
white
19.699219
47
0.734985
0.584961
1
0
0
no
0.8
0.7
dnr before sadm
-1
113
5.799805
50
24
37.79688
371.375
2.099609
4.299805
1
142
7.479492
85
27
null
1
1
no(M2 and SIP pres)
1
592
0
71.34296
female
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
5
10
under $11k
9
18,782
14,517.0781
11,687.2188
17
white
20.898438
31
0.807983
0.743896
1
1
1
no
0.95
0.9
dnr before sadm
-1
60
10.898438
71
7
37.79688
164
3.199707
0.5
1.199951
145
7.489258
103
28
880
null
6
null
6
591
0
62.76797
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
null
0
14,804
10,534.9922
9,117.66406
13.5
white
27.898438
48
0.754883
0.67688
1
0
0
no
0.98
0.95
no dnr
10
112
3.799805
80
16
38.09375
314.25
3
null
1.599854
142
7.229492
145
27
3,050
0
0
no(M2 and SIP pres)
0
587
0
77.38794
male
0
62
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$25-$50k
0
276,475
null
null
28
white
26.398438
45
0.632935
0.530884
15
1
0
no
0.8
0.5
dnr after sadm
56
63
8
109
24
37.59375
225
2.799805
null
1.399902
133
7.279297
171
27
3,893
4
2
adl>=4 (>=5 if sur)
2
65
1
44.65698
female
0
43
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
162,599
101,252
88,088.6875
34.25
white
41.898438
92
0.409973
0.290955
28
0
0
no
0.6
0.5
no dnr
43
83
7.799805
62
22
35.79688
null
null
null
1.899902
140
null
97
51
2,000
0
0
SIP>=30
0
431
1
50.73798
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
null
0
59,439
34,156.6875
30,673.1562
42.333313
white
35.796875
45
0.653931
0.555908
1
1
0
no
0.3
0.2
dnr after sadm
6
68
12.298828
70
8
36
154
null
null
0.699951
147
7.349609
149
18
846
null
0
no(M2 and SIP pres)
0
350
1
73.40497
female
0
34
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
null
0
null
null
null
12.25
white
19.699219
33
0.836914
0.781982
1
0
0
no
0.7
0.55
no dnr
34
113
13.199219
110
28
36.09375
266.625
3.199707
8.199219
0.899902
140
7.469727
131
13
1,760
null
0
null
0
583
0
79.66296
male
1
24
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
null
61
62,999
40,298.4688
34,925.5
30
white
26.5
25
0.344971
0.228973
1
0
0
yes
0.2
0.1
dnr after sadm
6
53
0.099991
145
22
38.39844
152.84375
2
0.699951
0.799927
150
7.329102
245
35
4,700
null
0
<2 mo. follow-up
0
24
1
69.08099
male
1
14
Coma
Coma
0
null
null
94
20,163
13,435.8359
12,427.9141
9
white
16.597656
28
0.411987
0.337952
1
0
0
no
0.3
0.25
dnr after sadm
2
49
11.798828
67
12
36.69531
167.5
2.699707
1.199951
1.5
136
7.359375
184
31
2,311
null
null
<2 mo. follow-up
2.091797
14
1
27.584
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
19,892
12,599.1016
10,366.0469
46
white
37
39
0.74292
0.662964
1
0
0
no
null
null
no dnr
4
51
14
120
46
38.5
235
2.399902
0.699951
1.799805
143
7.349609
152
38
2,304
null
null
<2 mo. follow-up
2.062988
4
1
86.26996
female
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
3
8
$11-$25k
0
9,650
5,775.1953
5,304.49609
6
white
21
32
0.775879
0.702881
1
0
0
no
0.9
0.8
dnr after sadm
1
113
7.599609
70
16
36.69531
603.25
null
null
7.799805
142
7.109375
225
33
0
6
null
SIP>=30
4.527344
565
1
61.35199
female
0
54
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
0
234,324
137,719.875
111,101.25
42.75
white
20.097656
25
0.841919
0.787964
4
0
0
no
0.2
0.2
no dnr
54
70
17.5
144
11
39.79688
200
2.199707
0.199982
0.699951
141
7.319336
164
12
3,780
null
0
adl>=4 (>=5 if sur)
0
575
0
77.758
female
1
30
ARF/MOSF w/Sepsis
ARF/MOSF
2
6
under $11k
37
146,557
89,139.1875
77,811.75
42
black
20.097656
44
0.630981
0.528931
12
0
0
no
0.2
0.1
dnr after sadm
24
77
15.199219
124
36
38.09375
253.03125
2.899902
1.099854
1.899902
134
7.319336
224
81
1,225
null
null
<2 mo. follow-up
2.732422
30
1
80.35297
male
0
21
Coma
Coma
2
15
$11-$25k
44
29,080
20,074.9531
16,646.2969
19
white
27.199219
33
0.241974
0.175995
1
0
1
no
0.95
0.75
dnr after sadm
2
77
5.599609
60
20
36.09375
null
null
null
2.399902
133
null
82
61
null
null
7
adl>=4 (>=5 if sur)
7
176
1
84.22699
male
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
36,814
20,278.5469
29,629.5
16
null
25.398438
22
0.546997
0.432983
13
0
0
yes
0.1
0
dnr after sadm
1
102
12.599609
80
20
36.09375
null
null
null
1.799805
136
null
163
36
null
null
null
<2 mo. follow-up
2.511719
7
1
82.63397
female
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$11-$25k
0
82,585
45,284.7188
44,555.9688
33.666657
white
32.296875
54
0.470947
0.35199
1
0
0
yes
0.2
0.15
no dnr
22
68
11.599609
150
24
40
136.65625
4.5
0.5
3.299805
138
7.519531
146
55
1,040
null
2
<2 mo. follow-up
2
30
1
59.03098
female
0
4
CHF
COPD/CHF/Cirrhosis
4
null
null
0
3,748
2,022.1465
1,725.2998
15
white
15.699219
33
0.911987
0.851929
1
0
0
no
null
null
no dnr
4
110
4.5
80
20
36.09375
338.0625
null
null
9.099609
141
7.289062
78
119
1,950
null
null
null
2.114746
570
0
49.95499
female
0
4
Lung Cancer
Cancer
1
14
under $11k
0
12,992
6,650.6328
3,013.5
16
black
19.097656
11
0.700928
0.414978
1
0
0
metastatic
null
null
no dnr
4
107
24.5
80
26
37.09375
77
null
null
0.5
134
7.439453
144
11
690
null
null
no(M2 and SIP pres)
2.111816
148
1
70.02594
male
0
5
ARF/MOSF w/Sepsis
ARF/MOSF
3
11
null
9
18,838
11,435.375
9,491.6875
10
white
22.296875
40
0.737915
0.655884
8
0
0
no
null
null
no dnr
5
67
8.298828
57
8
38.19531
156
4.599609
0.599976
1
140
7.329102
107
10
1,410
null
null
null
3.227051
569
0
50.87198
female
1
14
ARF/MOSF w/Sepsis
ARF/MOSF
2
18
null
9
60,732
36,637.6875
36,468.25
14.666664
white
24.097656
27
0.767944
0.69397
20
1
1
no
0.8
0.8
dnr after sadm
7
47
15.199219
77
9
36
154.53125
2.799805
0.299988
2.799805
134
7.349609
113
48
2,015
null
null
<2 mo. follow-up
4.767578
14
1
73.03198
male
0
29
Coma
Coma
2
null
null
100
83,542
46,609.1562
49,510.8438
12.75
white
31.597656
52
0.008999
0.003
7
1
0
no
0
0
no dnr
29
73
12.599609
72
4
36.29688
null
2.599609
0.299988
0.899902
138
null
143
31
260
null
null
null
3.789063
564
0
75.96997
female
0
6
Colon Cancer
Cancer
3
13
null
9
9,781
5,472.5625
5,109.79688
16
white
15.5
11
0.794922
0.565918
1
0
0
metastatic
0.6
0.1
dnr after sadm
1
133
11.798828
140
40
37.89844
235
null
null
0.899902
141
7.279297
138
16
3,239
1
null
SIP>=30
1.166748
140
1
100.849
female
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
under $11k
9
10,535
5,857.9258
5,850.61719
26
white
20.097656
27
0.701904
0.611938
1
0
1
no
null
null
dnr after sadm
3
57
20.296875
70
25
36.69531
277.75
null
null
2.099609
132
7.399414
407
65
1,350
null
1
<2 mo. follow-up
1
26
1
89.56097
male
0
7
COPD
COPD/CHF/Cirrhosis
7
12
under $11k
0
10,879
7,056.1211
6,406.30859
9
white
18
51
0.691895
0.526978
1
1
0
yes
0.5
0.3
dnr before sadm
-1
67
15.099609
70
20
39.39844
233.3125
4.299805
0.5
2.399902
144
7.219727
176
36
3,600
1
5
<2 mo. follow-up
5
32
1
76.45197
male
0
3
CHF
COPD/CHF/Cirrhosis
5
16
$11-$25k
0
3,710
2,018.0147
2,550.81836
null
white
21.796875
39
0.753906
0.611938
1
1
0
yes
null
null
no dnr
3
60
6.599609
60
25
37.79688
232
null
null
1.199951
142
7.359375
98
21
null
0
null
no(M2 and SIP pres)
0.494751
563
0
86.71295
female
0
5
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
10,759
7,902.1875
6,759.37891
17
black
27.199219
36
0.655884
0.557983
1
0
0
no
1
1
no dnr
5
100
9.798828
100
20
35.89844
113.32812
null
null
1.599854
143
7.259766
208
41
900
0
null
no(M2 and SIP pres)
0.494751
417
1
88.099
female
1
4
COPD
COPD/CHF/Cirrhosis
3
12
null
41
6,003
3,062.8555
3,021.33984
16
white
25.597656
40
0.309998
0.129974
1
0
0
yes
0.05
0
dnr before sadm
-1
67
24.898438
160
30
40
157.5
null
null
1.899902
140
7.489258
166
78
2,510
null
null
<2 mo. follow-up
4.37207
4
1
73.08997
male
0
3
Colon Cancer
Cancer
1
15
>$50k
0
3,504
null
null
null
white
10.199219
13
0.880981
0.72998
1
0
0
metastatic
null
null
no dnr
3
51
16.398438
65
24
35.59375
null
2.699707
0.399963
0.699951
147
null
88
22
3,020
null
null
no(M2 and SIP pres)
1.600342
560
0
41.06
male
1
11
Cirrhosis
COPD/CHF/Cirrhosis
4
12
null
9
34,565
22,094.8281
16,700.625
14.5
white
16.699219
11
0.890991
0.816895
1
0
0
no
0.5
0.3
dnr after sadm
11
66
10.898438
66
22
36.59375
73
3.899902
null
1.699951
139
7.459961
132
31
3,420
null
1
<2 mo. follow-up
1
11
1
79.38696
female
0
8
CHF
COPD/CHF/Cirrhosis
3
null
null
0
10,367
6,241.707
5,594.46875
11.5
white
19.699219
24
0.81897
0.706909
1
0
0
no
0.93
0.9
no dnr
8
60
16.296875
106
24
36.89844
250
2.699707
0.5
0.699951
151
7.349609
222
35
1,060
null
null
null
3.145508
559
0
88.04095
female
0
12
CHF
COPD/CHF/Cirrhosis
2
12
>$50k
9
14,197
7,723.1719
6,765.10938
16.5
white
19.398438
26
0.764893
0.626953
1
0
0
no
0.75
0.65
no dnr
12
105
10
85
20
36
null
4.099609
0.299988
1.299805
133
null
164
9
null
null
1
no(M2 and SIP pres)
1
129
1
72.02496
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
5
11
null
9
26,558
15,732.0469
13,939.625
12.666664
white
30.5
34
0.547974
0.434998
1
1
0
yes
0.95
0.9
no dnr
14
73
9.599609
70
20
36.69531
null
null
null
2.599609
140
null
168
53
275
1
1
SIP>=30
1
557
0
63.95599
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
1
17
$25-$50k
0
23,886
16,045.0391
12,984.2344
13.666664
black
42.398438
71
0.392944
0.273987
1
0
0
no
0.75
0.7
no dnr
15
111
11.199219
70
12
36.09375
312
2.5
null
0.599976
137
7.5
147
23
980
0
0
SIP>=30
0
78
1
59.129
male
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
null
0
71,912
null
null
36.333313
white
35.898438
42
0.603882
0.496948
1
1
0
no
0.6
0.55
no dnr
20
51
12.699219
76
24
36.09375
612
2.899902
0.299988
2.599609
146
7.119141
86
41
2,000
null
0
no(M2 and SIP pres)
0
94
1
44.78
male
0
7
Colon Cancer
Cancer
1
17
>$50k
0
9,059
4,849.8164
4,319.27734
6
black
17.898438
16
0.840942
0.650879
1
0
0
metastatic
0.99
0.75
no dnr
7
107
10.298828
80
26
36.29688
176.65625
3.099609
0.399963
3.899902
143
7.419922
193
90
521
0
0
no(M2 and SIP pres)
0
552
0
33.73898
female
1
37
Cirrhosis
COPD/CHF/Cirrhosis
3
16
>$50k
0
156,416
93,311.875
85,475.5
33.25
white
21.097656
39
0.889893
0.815918
1
0
0
no
0.9
0.9
dnr after sadm
35
49
5.199219
138
52
38.09375
131
1.899902
null
2.399902
138
7.259766
160
52
1,937
0
0
<2 mo. follow-up
0
37
1
63.39798
female
0
8
COPD
COPD/CHF/Cirrhosis
5
12
null
0
10,480
6,736.8789
6,319.29688
5.5
white
25.597656
63
0.804932
0.684937
1
1
0
no
0.7
0.5
no dnr
8
48
18.097656
131
14
39.19531
140
2.699707
null
1.399902
148
7.349609
164
19
2,095
1
null
no(M2 and SIP pres)
1.166748
551
0
74.58997
female
0
23
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
9
30,041
16,481.7656
15,869.3984
13.333328
white
24.097656
36
0.724976
0.570923
1
0
1
no
0.5
0.3
dnr after sadm
1
60
14.798828
80
13
36.69531
405
3.299805
0.899902
1.399902
151
7.469727
92
67
3,775
null
null
adl>=4 (>=5 if sur)
5.701172
551
0
43.93399
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
0
40,720
28,689.8125
23,171
32.5
black
24.199219
22
0.86499
0.817993
1
1
0
no
0.7
0.65
no dnr
11
46
8.5
71
24
36.09375
217.5
3.699707
0.899902
1.699951
143
7.419922
119
19
3,835
null
0
no(M2 and SIP pres)
0
551
0
74.54095
male
1
17
Colon Cancer
Cancer
2
17
null
0
28,086
16,028.0312
22,764.7188
18.666656
white
21.5
37
0.7229
0.447998
1
1
0
metastatic
0.5
0.2
dnr after sadm
16
64
6.5
55
15
36.39844
376.625
null
0.5
0.899902
136
7.449219
314
15
380
1
1
<2 mo. follow-up
1
17
1
61.76297
female
1
7
COPD
COPD/CHF/Cirrhosis
3
null
null
0
9,606
4,910.543
4,906.23828
8
white
25.296875
17
0.723999
0.56897
1
0
0
metastatic
0
0
dnr after sadm
1
51
9.898438
126
20
39.09375
85.70312
2.5
1.599854
0.699951
149
7.369141
404
11
6,020
null
null
<2 mo. follow-up
3.388672
7
1
31.75899
female
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
>$50k
0
13,281
9,716.3906
10,160.5859
14.5
white
21.199219
25
0.891968
0.853882
1
0
0
yes
1
0.98
no dnr
9
103
6.799805
80
20
36.09375
185
null
null
1.799805
136
7.329102
124
42
785
0
0
no(M2 and SIP pres)
0
550
0
80.73395
female
0
13
CHF
COPD/CHF/Cirrhosis
5
12
null
0
13,755
8,092.8984
7,498.60938
6.5
white
20.898438
34
0.748901
0.60498
1
1
0
yes
0.9
0.75
no dnr
13
70
10.5
100
12
38.5
150
2.199707
0.5
1
137
7.389648
110
13
2,660
2
5
no(M2 and SIP pres)
5
485
1
57.44299
male
0
6
CHF
COPD/CHF/Cirrhosis
5
12
>$50k
0
16,060
9,673.1953
9,316.52344
26
white
22.097656
36
0.860962
0.769897
1
1
0
no
0.9
0.65
no dnr
6
63
24.296875
80
8
36.89844
191.65625
1.699951
null
1.399902
132
7.489258
279
30
4,375
0
null
no(M2 and SIP pres)
0.494751
544
0
90.409
female
0
9
CHF
COPD/CHF/Cirrhosis
5
null
under $11k
0
15,787
9,226.8359
9,466.40625
15
white
25.398438
38
0.666992
0.492981
1
0
0
no
0.6
0.5
dnr after sadm
1
105
7.399414
71
20
36.29688
null
3.199707
0.699951
1.699951
142
null
116
29
null
null
null
<2 mo. follow-up
4.740234
47
1
64.47595
male
0
55
Coma
Coma
3
12
under $11k
41
69,165
43,183.8125
54,610.9062
15.5
white
22
34
0.567993
0.500977
1
0
0
no
0.2
0.1
no dnr
55
46
14.5
59
12
38.59375
423.3125
2.299805
null
0.699951
142
7.329102
174
19
2,250
null
null
adl>=4 (>=5 if sur)
2.977051
215
1
91.55896
female
1
11
Coma
Coma
1
6
under $11k
41
10,485
6,151.1875
5,817.13672
20
white
28.398438
43
0.128998
0.081985
1
0
1
no
0.1
0.02
dnr before sadm
0
115
12.298828
69
28
35.79688
148.3125
null
null
0.899902
134
7.429688
107
10
1,300
null
7
<2 mo. follow-up
7
11
1
73.69995
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
0
25,804
15,467.3672
14,347.2891
10
white
29
38
0.541992
0.426941
1
1
0
metastatic
0.05
0.02
dnr after sadm
5
73
26
110
12
36
70
2.299805
0.5
1.599854
143
7.469727
149
20
949
null
null
no(M2 and SIP pres)
3.779297
212
1
72.41095
male
1
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
67,720
48,275.4062
38,954.9688
35.333313
white
35
84
0.488953
0.370972
4
1
0
no
0.3
0.2
dnr after sadm
14
103
6.299805
80
20
36.09375
null
4.399414
0.599976
5.899414
135
null
91
82
975
1
null
<2 mo. follow-up
1.166748
16
1
46.06699
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
$25-$50k
0
25,496
16,835.1719
14,268.125
14
hispanic
16.398438
28
0.922974
0.894897
1
1
0
no
1
1
no dnr
12
93
6.599609
96
28
36.5
null
null
null
0.599976
137
null
96
11
2,220
0
0
no(M2 and SIP pres)
0
538
0
87.63599
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
0
25,788
16,038.0859
16,481.7188
16.333328
white
15.699219
29
0.843994
0.790894
1
1
0
no
0
0
no dnr
15
117
13.298828
80
25
37.79688
null
2.099609
0.399963
4.299805
145
null
118
116
2,050
2
1
adl>=4 (>=5 if sur)
1
150
1
72.46295
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
null
0
15,090
8,748.4688
9,523.88281
17
white
29.699219
49
0.605957
0.498962
1
1
0
yes
0.7
0.6
no dnr
10
79
6.599609
117
25
38.09375
null
null
0.299988
0.5
130
null
307
2
2,675
1
2
no(M2 and SIP pres)
2
291
1
76.71497
male
0
14
CHF
COPD/CHF/Cirrhosis
5
16
>$50k
9
20,323
11,287.5625
10,315.9766
9.666664
white
37.695313
40
0.397949
0.200989
1
0
0
no
0.7
0.6
no dnr
14
52
7.899414
106
10
38.5
null
null
21
1.099854
138
null
330
null
735
0
6
no(M2 and SIP pres)
6
517
1
69.75995
male
0
19
Cirrhosis
COPD/CHF/Cirrhosis
4
12
$11-$25k
0
54,999
36,966.5938
30,630.125
23.666656
white
23.597656
48
0.656982
0.47998
1
0
0
no
0.3
0.1
dnr after sadm
13
87
15.898438
80
20
37
null
3.399902
0.5
1.099854
139
null
196
17
1,500
1
0
no(M2 and SIP pres)
0
534
0
90.84198
female
0
7
CHF
COPD/CHF/Cirrhosis
6
null
null
0
8,074
4,425.0781
4,210.80859
10
white
16.796875
31
0.771973
0.636963
1
1
1
yes
0.9
0.6
dnr before sadm
0
72
10.898438
72
24
36.19531
225.6875
null
null
1.899902
141
7.399414
133
58
2,300
null
4
adl>=4 (>=5 if sur)
4
171
1
57.133
female
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
$25-$50k
0
17,320
11,057.3828
9,200.57812
18
white
19.5
46
0.879883
0.837891
1
1
0
no
0.8
0.7
no dnr
7
83
7.899414
70
30
36.09375
190.46875
3.599609
0.799927
1
142
7.459961
117
27
500
0
0
no(M2 and SIP pres)
0
532
0
79.64697
male
0
6
CHF
COPD/CHF/Cirrhosis
5
14
$11-$25k
0
7,423
3,945.709
3,609.30859
7
white
20.699219
28
0.702881
0.540894
1
1
0
metastatic
0.75
0.5
dnr after sadm
2
65
7.099609
60
18
36.19531
null
null
null
2.299805
134
null
283
51
1,700
2
1
adl>=4 (>=5 if sur)
1
270
1
84.15594
female
0
13
COPD
COPD/CHF/Cirrhosis
3
16
under $11k
0
30,009
19,574.5
16,739.9688
31
white
20.699219
32
0.741943
0.593994
1
1
0
no
0.95
0.75
dnr after sadm
11
109
23.5
50
10
36.39844
224.4375
null
1.399902
1.099854
140
7.529297
167
18
2,675
1
5
adl>=4 (>=5 if sur)
5
526
0
74.74896
male
1
7
Coma
Coma
2
16
null
100
22,690
13,871.0312
13,232.1172
13
white
25.699219
47
0.092987
0.054993
1
0
0
no
0.2
0.1
dnr after sadm
5
69
5.299805
65
24
36.59375
161.65625
null
null
3
139
7.189453
99
42
1,500
null
1
<2 mo. follow-up
1
7
1
89.71399
male
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
1
17
null
0
48,745
34,818.8125
28,514.3281
42
white
40.195313
52
0.195984
0.103989
1
0
0
yes
0.1
0.1
no dnr
22
113
14
70
20
38.29688
247.59375
2.899902
0.599976
1
130
7.519531
171
17
6,625
null
0
no(M2 and SIP pres)
0
524
0
63.51297
female
0
37
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
under $11k
0
193,988
null
null
36.75
white
29
63
0.659912
0.56189
10
0
0
no
0.8
0.7
dnr after sadm
14
53
8.898438
120
20
37
196.28125
null
null
1.099854
148
7.269531
136
43
null
null
1
adl>=4 (>=5 if sur)
1
523
0
75.92096
male
0
7
COPD
COPD/CHF/Cirrhosis
2
13
$11-$25k
0
17,128
10,540.1797
8,673.13281
14
white
19.5
38
0.814941
0.700928
1
0
0
no
0.85
0.75
no dnr
7
100
14
70
30
36.09375
428.5625
4.199219
0.699951
1.199951
139
7.539062
118
12
null
0
0
no(M2 and SIP pres)
0
522
0
67.38696
female
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
9
50,514
30,673.5781
27,778.4688
15.5
white
17.796875
22
0.806885
0.74292
16
1
0
no
0.8
0.95
dnr after sadm
2
87
9.5
80
20
36.09375
null
2.599609
null
1.099854
132
null
81
23
null
6
6
no(M2 and SIP pres)
6
521
0
92.57196
male
0
6
Colon Cancer
Cancer
1
7
$11-$25k
9
5,912
3,369.0644
5,725.19922
6
white
16.296875
25
0.744995
0.481995
1
0
0
metastatic
0.5
0.25
dnr after sadm
1
72
13.199219
66
22
36.69531
null
null
1
0.699951
134
null
132
8
null
null
null
<2 mo. follow-up
3.660645
24
1
78.97296
male
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$11-$25k
0
45,546
27,270.8125
30,935.4688
13
white
26.5
40
0.496948
0.378967
6
0
0
metastatic
0.5
0.5
no dnr
9
77
5
110
20
36.09375
392.5625
null
null
1.199951
135
7.449219
112
21
1,100
0
0
no(M2 and SIP pres)
0
520
0
65.711
male
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
20,463
14,977.1953
11,637.0078
16.5
white
25.597656
51
0.779907
0.708984
1
1
0
no
0.8
0.6
no dnr
10
87
5.199219
80
25
36.09375
null
null
1.5
1.699951
143
null
111
46
null
0
1
no(M2 and SIP pres)
1
517
0
71.11597
male
1
12
Lung Cancer
Cancer
5
0
under $11k
0
15,720
8,923.6016
7,533.73828
16.5
white
29.296875
28
0.370972
0.085999
1
0
0
metastatic
0.65
0.4
no dnr
12
63
13.398438
114
20
36.09375
177.53125
2.599609
0.399963
3.599609
142
7.379883
157
79
3,550
null
6
<2 mo. follow-up
6
12
1
79.67694
male
0
11
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
11,104
6,684.3984
6,057.19922
6
white
25.296875
40
0.728882
0.576904
1
0
0
no
0.4
0.1
no dnr
11
46
15.199219
71
16
35.39844
168.5625
2.5
2
5.599609
128
7.289062
83
56
0
0
0
adl>=4 (>=5 if sur)
0
96
1
78.34399
male
0
42
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
171,445
92,540.1875
91,492.6875
52.25
white
29
51
0.658936
0.560913
1
1
0
no
0.1
0.1
no dnr
42
43
10.398438
107
14
38.29688
130
2
null
1.699951
136
7.40918
284
16
8,404
null
null
no(M2 and SIP pres)
2.36377
515
0
77.85895
male
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
4
16
$25-$50k
0
42,725
28,351.5156
23,872.6562
28.333328
white
27.5
58
0.628906
0.525879
1
1
0
yes
0.5
0.2
no dnr
15
77
13.898438
70
20
37.89844
null
3.299805
1.299805
1.299805
135
null
130
12
1,300
null
null
null
3.681152
514
0
75.88196
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
0
38,838
28,448.0156
23,182.7188
27.333328
white
34.398438
56
0.540894
0.426941
1
0
0
no
0.8
0.8
no dnr
14
55
2.599609
105
20
36.79688
420
1.5
0.799927
0.599976
141
7.429688
86
13
1,900
null
0
null
0
268
1
79.63599
male
0
10
CHF
COPD/CHF/Cirrhosis
3
null
null
0
17,408
10,100.2578
10,285.5781
17.5
white
24.597656
32
0.741943
0.593994
1
1
0
no
0.9
0.5
no dnr
10
57
23.398438
70
25
36.69531
195.21875
null
null
2
145
7.359375
224
50
1,780
1
0
adl>=4 (>=5 if sur)
0
513
0
53.952
male
0
4
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
$11-$25k
0
13,302
10,411.4531
7,114.89844
16
black
18.097656
47
0.897949
0.861938
1
0
0
no
null
null
no dnr
4
117
17.898438
100
20
38.29688
130
null
null
0.899902
151
7.149414
121
26
30
null
null
no(M2 and SIP pres)
2.271973
464
1
83.81396
male
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$25-$50k
0
27,338
19,948.9062
16,185.2344
34.5
white
38.898438
61
0.355957
0.238983
1
0
1
no
0.7
0.7
dnr after sadm
1
137
16.5
66
10
36.89844
120
3.599609
0.799927
0.699951
136
7.379883
315
15
2,680
null
6
<2 mo. follow-up
6
7
1
56.63498
female
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
0
119,068
69,944.5625
57,625.0938
38.5
white
28.398438
48
0.770996
0.697998
1
0
0
no
0.8
0.87
no dnr
26
62
10.199219
72
12
35.69531
null
null
null
1.199951
130
null
105
20
850
null
0
null
0
506
0
72.94196
female
1
5
COPD
COPD/CHF/Cirrhosis
3
null
null
0
16,909
10,511.6953
10,333.25
17
white
42.398438
74
0.221985
0.072998
1
0
0
yes
0.1
0.05
no dnr
5
97
12.199219
110
25
35.79688
420
3.199707
0.399963
0.699951
144
7.449219
158
11
null
null
null
<2 mo. follow-up
2.996094
5
1
70.07495
male
0
7
Lung Cancer
Cancer
3
19
$11-$25k
0
8,271
4,555.8086
3,788.14844
3.5
white
12.5
16
0.777954
0.536987
1
0
0
metastatic
0.5
0.25
dnr after sadm
4
79
6
70
24
36.29688
136.71875
3
0.399963
1
138
7.479492
146
17
1,850
0
0
null
0
152
1
70.21497
female
1
13
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
55,557
39,851.4688
31,419.3125
41.5
white
25
35
0.772949
0.699951
1
0
0
no
0.9
0.9
dnr after sadm
10
107
3.799805
80
20
36.69531
null
null
null
4.599609
135
null
105
53
825
null
1
<2 mo. follow-up
1
13
1
44.65997
female
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
94,668
63,825.6875
52,166.375
33
black
25.5
32
0.823975
0.764893
4
0
0
no
0.6
0.6
no dnr
25
117
6.5
82
20
35.89844
309.5
null
null
3.5
142
7.389648
226
55
5,860
null
0
no(M2 and SIP pres)
0
499
0
70.44995
female
0
7
COPD
COPD/CHF/Cirrhosis
3
null
null
0
6,921
3,909.4043
3,958.57812
5
white
16.699219
12
0.842896
0.741943
1
0
0
yes
0.9
0.9
no dnr
7
67
6.799805
64
12
36.39844
155.09375
null
0.399963
2.399902
141
7.329102
90
64
2,360
null
null
null
2.383301
499
0
64.89294
male
1
3
MOSF w/Malig
ARF/MOSF
1
12
$25-$50k
0
37,234
18,465.0625
17,193.8906
64
white
37.296875
47
0.260986
0.155975
1
0
0
metastatic
null
null
dnr after sadm
3
64
6.5
63
30
38.19531
126.65625
3.599609
1.099854
1.399902
143
7.399414
86
30
1,885
null
null
<2 mo. follow-up
2.459961
3
1
66.37598
female
0
7
CHF
COPD/CHF/Cirrhosis
5
10
null
0
8,253
4,674.8828
4,148.16797
6
black
19.398438
32
0.863892
0.775879
1
0
1
no
0.6
0.3
no dnr
7
60
17.5
40
20
35.79688
null
null
null
2.299805
150
null
98
93
925
null
6
<2 mo. follow-up
6
33
1
71.80798
male
1
7
Cirrhosis
COPD/CHF/Cirrhosis
3
16
$11-$25k
0
11,112
5,896.1367
4,721.4375
6.5
white
19.597656
26
0.590942
0.399963
1
0
0
metastatic
0.5
0.1
dnr after sadm
1
107
11.599609
116
28
35.29688
286.625
2.399902
null
0.699951
130
7.419922
260
21
null
0
5
<2 mo. follow-up
5
7
1
77.32794
male
1
14
MOSF w/Malig
ARF/MOSF
2
16
$25-$50k
0
38,514
null
null
11
white
31.296875
62
0.5
0.382996
1
0
0
yes
0.3
0.05
dnr after sadm
12
75
19.699219
108
32
35
240
1.799805
2.399902
4.399414
131
7.30957
214
67
285
null
0
<2 mo. follow-up
0
14
1
64.63196
female
0
11
Lung Cancer
Cancer
1
13
$25-$50k
0
13,459
7,567.1641
6,809.6875
13
white
30.398438
24
0.359985
0.078995
1
0
0
metastatic
0.5
0.05
no dnr
11
60
6.199219
75
22
36.59375
714.25
3.199707
0.5
0.599976
137
7.069336
400
10
9,000
1
1
no(M2 and SIP pres)
1
495
0
29.29799
male
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
$25-$50k
0
null
null
null
39
white
20.796875
38
0.899902
0.863892
7
0
0
no
0.8
0.8
null
null
116
10.699219
74
20
38.19531
272
3.699707
1.099854
0.899902
150
7.449219
209
30
690
null
0
no(M2 and SIP pres)
0
492
0
74.06195
male
1
25
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$25-$50k
41
87,620
55,738.7812
50,875.25
38.5
white
23.097656
49
0.651978
0.552979
1
0
0
no
0.1
0.05
dnr after sadm
22
64
19.699219
60
24
37.39844
76.65625
null
null
1.899902
135
7.269531
331
40
3,310
null
1
<2 mo. follow-up
1
25
1
63.22198
male
0
8
Cirrhosis
COPD/CHF/Cirrhosis
4
13
under $11k
0
11,623
6,085.7773
5,021.25781
5.5
white
17.898438
13
0.803955
0.68396
1
1
0
no
0.75
0.5
no dnr
8
43
11.699219
70
20
35.59375
135
null
null
2
139
7.439453
93
54
1,075
3
3
no(M2 and SIP pres)
3
225
1
83.65198
female
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
21,889
14,486.3828
11,581.4766
15.5
null
26.898438
34
0.677979
0.583984
1
0
0
no
1
1
no dnr
9
76
17.5
114
28
36.39844
322.1875
2
2.399902
0.799927
141
7.439453
101
21
910
null
null
no(M2 and SIP pres)
3.121094
492
0
70.08899
female
0
8
CHF
COPD/CHF/Cirrhosis
4
12
$11-$25k
0
8,502
4,805.1172
5,592.79688
9.5
white
25.398438
35
0.771973
0.636963
1
1
0
no
0.6
0.4
no dnr
8
107
10.398438
90
20
37
220
null
null
1.5
140
7.449219
179
23
800
0
0
no(M2 and SIP pres)
0
491
0
82.57098
female
0
5
CHF
COPD/CHF/Cirrhosis
3
8
null
0
5,274
2,972.1348
2,830.97852
20
white
20.296875
32
0.797974
0.674927
1
1
0
no
0.8
0.65
no dnr
5
117
18.097656
140
30
40.19531
162.5
4
0.599976
1.099854
141
7.459961
151
19
1,625
2
2
no(M2 and SIP pres)
2
490
0
74.21796
male
0
7
CHF
COPD/CHF/Cirrhosis
4
12
$25-$50k
0
10,267
5,255.0938
4,792.94922
5
white
20.199219
50
0.829956
0.7229
1
1
0
no
0.91
0.9
no dnr
7
55
14.599609
80
8
37.69531
374.25
2.199707
0.699951
1.599854
136
7.319336
261
44
1,970
1
1
SIP>=30
1
207
1